I remain committed to partnering with this Administration and Ranking Member Wyden to enact policies that realign incentives in the prescription drug supply chain, expand access to telehealth, and ensure long-term stability in our physician payment system.
Partner with the Administration and Ranking Member Wyden to enact policies that realign incentives in the prescription drug supply chain, expand access to telehealth, and ensure long-term stability in the physician payment system.
Occurrences
I remain committed to advancing [the targeted biosimilar access policy] ... I look forward to working together to move this policy through the Committee ... working to pursue its full Senate passage and enactment.
Evidence
Senate Finance Committee Ranking Member Mike Crapo and Chair Ron Wyden released a bipartisan framework to pursue legislative solutions to modernize and enhance federal prescription drug programs. Crapo said he thanked Wyden for working with him to improve prescription drug access and affordability and said he looked forward to discussing consensus-based solutions with colleagues.
The Finance Committee released a white paper outlining policy concepts related to reforming the way physicians are paid by Medicare and meeting the needs of those with chronic illness. The paper said the committee saw opportunities for reform including creating sustainable payment updates, improving primary care, supporting chronic care benefits, and ensuring continued access to telehealth.
The White House stated that the Working Families Tax Cuts Act signed into law on July 4, 2025 created the Rural Health Transformation Program and invested $50 billion over five years to transform rural health access.
Crapo said the law makes health care more accessible and affordable and highlighted key wins including increased access to zero-deductible telehealth services. The release also said the Finance Committee provisions in the Working Families Tax Cuts Act expanded access to health savings accounts and made a transformational investment in rural health care systems.
Crapo said that working in partnership with Ranking Member Wyden, the Finance Committee delivered on its commitment to bring transparency and accountability to the prescription drug supply chain through pharmacy benefit manager reform. He said the bipartisan law would end perverse incentives for PBMs to steer patients toward higher-cost drugs and vertically integrated pharmacies.
The Senate Finance Committee says Crapo and Wyden released a bipartisan framework to pursue legislative solutions on prescription drug programs, including lower drug costs, transparency, and changes to PBM incentives and pharmacy access.
Finance Committee leadership announced the Modernizing and Ensuring PBM Accountability Act, describing it as legislation to increase transparency, accountability, and competition in the pharmaceutical supply chain, and noting it reflected the committee's chairman's mark.
The Finance Committee released a white paper on reforming Medicare physician payment and explicitly said one area of interest was ensuring continued access to telehealth, but it remained a policy paper rather than enacted law.
Crapo stated that the enacted funding package included significant reforms from the Finance Committee's PBM package that would increase transparency in Medicare Part D and lower seniors' pharmacy costs, and that telehealth flexibilities were being extended.
Crapo's committee statement says bipartisan health legislation had addressed prescription drug supply-chain issues and telehealth, but it does not show enactment of a long-term physician payment stabilization fix.
Assessments
Crapo materially advanced and obtained enactment of major pieces of the promise during his current Senate term: bipartisan PBM/prescription-drug supply-chain reforms and expanded or extended telehealth access were included in enacted legislation, with evidence tying those provisions to Finance Committee work with Wyden and the Administration. However, the promise also included ensuring long-term stability in the physician payment system, and the record shows only a white paper and policy development on Medicare doctor pay reform, not an enacted long-term stabilization fix. Because substantial components were delivered but one core component remains undelivered, the best classification is partial rather than delivered.
The evidence supports enactment of prescription drug supply-chain/PBM reforms and some expansion of telehealth access during the same Senate term. However, the promise also required ensuring long-term stability in the physician payment system, and the provided evidence shows only a Finance Committee white paper and policy development on that component, not enacted long-term physician payment stabilization. Because major parts were delivered but one core promised outcome remains unfulfilled, the appropriate outcome is partial; Crapo made serious bipartisan legislative efforts, so the effort badge applies.